Together, these results implied that follistatin protects mice by preserving the metabolic health of skeletal muscles and maintaining skeletal muscle function during HFD intervention, which may lessen the consequences of diet-induced obesity, such as sarcopenia. Here, FST is linked to obesity due to melanocortin 4 receptor deficiency.